StockData
Actuate Therapeutics, Inc. logo

Actuate Therapeutics, Inc. (ACTU) stock

ACTUNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 0/30
$0.25−0.02 (-6.12%)

Close on Nov 17, 2026Market cap $6.04MP/E –Yield –

Actuate Therapeutics total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Actuate Therapeutics's total debt was $404.99K at Sep 30, 2026. For fiscal 2025 it was $404.99K.

Annual total debt

PeriodPeriod endValueChange
FY2025Dec 31, 2025$404.99K–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$404.99K–
Q4 FY2025Dec 31, 2025$404.99K–

More Actuate Therapeutics figures

See a number that looks wrong?